(Biochem Pharmacol 2018) documented a reduction of -35% in white adipose tissue, -40% in adipocyte volume, -5.1% in body weight and -30% in plasma cholesterol in just 11 days in obese mice (DIO), without any change in food intake
Reported outcomes include potential improvements in immune function markers, sleep quality measures, and certain hormonal parameters
Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)
Laboratory research suggests AHK-Cu promotes dermal papilla cell proliferation while reducing programmed cell death (apoptosis), helping researchers better understand the biological processes involved in maintaining healthy follicle function
For general mast cell stabilization, KPV does not distinguish between different allergen triggers, so it should help reduce reactivity regardless of the specific allergen